Sky Century InvestmentSKYI 25 Current Ratio is 0.01 as of Feb. 2026, which is at its 10-year median of 0.01. GuruFocus rates SKYI with a GF Score™ of 25/100. The stock has 5 warning signs investors should review. Among 995 Drug Manufacturers companies, Sky Century Investment ranks worse than 99.7% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sky Century Investment's current ratio for the quarter that ended in Feb. 2026 was 0.01.
Sky Century Investment has a current ratio of 0.01. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Sky Century Investment has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Sky Century Investment's Current Ratio or its related term are showing as below:
SKYI'
s Current Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.01 Max: 0.09
Current: 0.01
During the past 6 years, Sky Century Investment's highest Current Ratio was 0.09. The lowest was 0.01. And the median was 0.01.
SKYI's Current Ratio is ranked worse than 99.7% of 995
companies
in the Drug Manufacturers industry
Industry Median: 2
vs SKYI: 0.01
Sky Century Investment (OTCPK:SKYI) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sky Century Investment Current Ratio Related Terms
Sky Century Investment Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKYI vs IMCC, PLSH, BSPK: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sky Century Investment's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sky Century Investment Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sky Century Investment's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sky Century Investment's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sky Century Investment (SKYI) has a Current Ratio of 0.01 as of Feb. 2026. This is near median its historical median of 0.01. Over the past decade, Sky Century Investment's Current Ratio has ranged from 0.01 to 0.09. According to the industry distribution chart, Sky Century Investment ranks #992 out of 995 companies in the Drug Manufacturers industry, placing it in the top 99.7%.
Is Sky Century Investment's Current Ratio too high?
Sky Century Investment's current Current Ratio of 0.01 is near median its 10-year median of 0.01. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.09. The Drug Manufacturers industry median Current Ratio is 2.00. Sky Century Investment's value of 0.01 is 99.5% below this industry median. Based on the distribution chart, Sky Century Investment ranks #992 out of 995 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sky Century Investment has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Sky Century Investment's Current Ratio compare to IMCC and PLSH?
According to the Drug Manufacturers industry distribution chart, Sky Century Investment ranks #992 out of 995 companies for Current Ratio. This places Sky Century Investment in the lower half of its industry. The industry median Current Ratio is 2.00. Sky Century Investment's value of 0.01 is 99.5% below this benchmark. Historically, Sky Century Investment's own Current Ratio has ranged from 0.01 to 0.09 over the past decade. While the company's 10-year median is 0.01 vs. the industry median of 2.00, Sky Century Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sky Century Investment's current Current Ratio of 0.01 is 99.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sky Century Investment's current Current Ratio is 0.01, which is near median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sky Century Investment stock overvalued right now?
Sky Century Investment (SKYI) has a current Current Ratio of 0.01. The current Current Ratio is 0.01, which is near median its 10-year median of 0.01 and 99.5% below the Drug Manufacturers industry median of 2.00. Sky Century Investment's overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sky Century Investment (SKYI), the current Current Ratio is 0.01 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sky Century Investment Inc operates four primary business lines, with profits generated from IT Services, including Technical Support and Server Leasing, and from the sale of RSS feeds and Podcasts. The IT Services segment provides ongoing technical support, maintenance, system upgrades, and high-performance server leasing, supporting growing demand for cloud solutions, data management, and network infrastructure. The Company also owns the Cannabis News application, a mobile platform that aggregates cannabis-related news from diverse sources and delivers real-time updates, though it is not commercially viable and has not generated revenue to date. The Company operates in competitive markets across IT services, marketing services, RSS feed services, and the cannabis industry.
25GF Score
Get the complete analysis for SKYI
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKYI has been successfully added to your 
